#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians treating older adults need to understand that edibles represent a growing consumption method in this population, which has different pharmacokinetics and safety profiles compared to smoked cannabis, including delayed onset and prolonged effects that increase overdose and fall risk. This demographic shift requires updated clinical screening and counseling protocols, particularly given older adults’ polypharmacy and age-related vulnerabilities to cannabis-related adverse effects. Understanding why seniors choose edibles can inform more targeted patient education and help clinicians anticipate potential drug interactions and complications in this increasingly common user group.
A recent study published in JAMA Network Open examined patterns of cannabis edible use among older adults, identifying reasons why this population is increasingly turning to oral formulations rather than smoked products. Researchers found that older adults prefer edibles for their perceived safety, ease of use, longer duration of effect, and reduced respiratory concerns compared to smoking, alongside therapeutic interest in pain management, sleep improvement, and anxiety relief. These findings reflect a significant shift in cannabis consumption methods among seniors and suggest that edible formulations may be better tolerated in an aging population with multiple comorbidities and polypharmacy concerns. However, the study also highlights risks particular to older adults, including delayed onset of effects leading to unintentional overdosing, cognitive and fall risks, and potential drug-drug interactions that clinicians should counsel patients about. Clinicians caring for older adults should anticipate questions about cannabis edibles, understand their patients’ motivations for use, and provide evidence-based guidance on dosing, onset timing, and interaction risks specific to aging populations.
“What we’re seeing clinically is that older adults are gravitating toward edibles because they avoid the respiratory risks of smoking and offer more predictable dosing than inhalation, but they’re underestimating the delayed onset and prolonged effects, which leads to accidental overdosing and falls that could have been prevented with proper patient education.”
🧓 As older adults increasingly turn to cannabis edibles for pain, sleep, and anxiety management, clinicians should recognize this trend while understanding its distinct risks in this population. Edibles present particular challenges in geriatric care because of delayed onset and prolonged effects that can lead to accidental overdosing, falls, and drug interactions with common medications like anticoagulants and sedatives. The appeal of edibles—convenience, discretion, and perceived safety compared to smoking—may mask serious concerns including cognitive impairment, orthostatic hypotension, and cannabinoid hyperemesis syndrome, all of which can be especially consequential in older patients with multiple comorbidities. When counseling older patients about cannabis use, clinicians should directly ask about edible consumption patterns, discuss onset timing and individual variability in metabolism, and emphasize the importance of starting with low doses and documenting use in the medical record. Given the regulatory gaps
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
